The Immunobuddies

The Immunobuddies

Por: Dr Ricky Frazer and Dr Anna Olsson-Brown
Buddies with an interest in the area of immunotherapy and its development. We simply discuss the dilemmas, challenges and progress made in the management of patients receiving immunotherapies to treat cancer.
175 episodios disponibles

Latest episodes of the podcast The Immunobuddies

Mostrando página 3 de 9

Episode 135: New and Novel Immunotherapy - ICANS - Practical Approach to Management with Dr. Frederick Vonberg Institute of Neurology University College London 28/03/2025
Episode 134: New and Novel Immunotherapy - Demystifying ICANS - Overview, Mechanism of Toxicity and Mimics with Dr. Frederick Vonberg Institute of Neurology University College London and Harvard Medical School 21/03/2025
Episode 133: Exploration immunotherapy in Merkel Cell and Basal Cell Carcinoma with Professor Axel Hauschild Head of the Skin Cancer Trial Center at the University Hospital Schleswig-Holstein, Campus Kiel, Germany 14/03/2025
Episode 132: Exploration of new immunotherapy approaches in Skin Cancers with Professor Axel Hauschild Head of the Skin Cancer Trial Center at the University Hospital Schleswig-Holstein, Campus Kiel, Germany 07/03/2025
Episode 131: All Skin Cancer Demystified. Is Neoadjuvant Immunotherapy really the panacea? with Professor Axel Hauschild Head of the Skin Cancer Trial Center at the University Hospital Schleswig-Holstein, Campus Kiel, Germany 28/02/2025
Episode 130: Lung Cancer (Mesothelioma) Immunotherapy Toxicities and Future with Dr Adam Januszewski 21/02/2025
Episode 129: Lung Cancer (Mesothelioma) Role Of Immunotherapy with Dr Adam Januszewski 14/02/2025
Episode 128: Lung Cancer (Mesothelioma) with Dr Adam Januszewski 07/02/2025
Episode 127: Personalised Immunotherapy Final Part - the future potential with Dr Paolo Ascierto 31/01/2025
Episode 126: Personalised Immunotherapy - How do we apply in real world practice? With Dr Paolo Ascierto 24/01/2025
Episode 125: Personalised Immunotherapy - What does this mean? With Dr Paolo Ascierto Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy at the National Tumor Institute Fondazione G. Pascale in Naples (Italy) 17/01/2025
Episode 124: Curenetics Final Part - The Bonus episode - A first for the immunobuddies! How should we apply the tool to future clinical trials? 10/01/2025
Episode 123: Curenetics Part 3 - Can we apply to Toxicity Prediction and how do we integrate this tool in future? 03/01/2025
Episode 122: Curenetics Part 2 Practical Applications of the 4 Components to Predict response to checkpoint inhibitors in the real world 27/12/2024
Episode 121: Christmas Special - Curenetics - Can we use AI to Predict Response to Checkpoint Inhibitor Immunotherapy? With Founder and CMO Dr Sola Adeleke and Team 20/12/2024
Episode 120: Uveal Melanoma and the Data that supports the Newly NICE Approved Tebentafusp and Future Developments with Dr Joe Sacco 13/12/2024
Episode 119: Uveal Melanoma and the Role of Immunotherapy in metastatic disease with Dr Joe Sacco 06/12/2024
Episode 118: Ocular (Uveal and Conjunctival) Melanoma and the Role of Immunotherapy Demystified with Dr Joe Sacco 29/11/2024
Episode 117: Gastro Toxicities with Professor Nick Powell - Role of endoscopy and how to approach the conversation! 22/11/2024
Episode 116: Gastro Toxicities with Professor Nick Powell - Role of topical steroids, Infliximab 15/11/2024
« Primera ‹ Anterior 1 2 3 4 5 ... 9 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA